1
Non-oliguric acute renal failure lnulin backleak Pulmonary tuberculosis Diagnosis Laboratory tests Tubule secretion of PAH lnulin clearance Tubule cation transport Pathology Roentgenology Myers BD, Hilberman M, Spencer RJ, Jamison RL: Glomarular and tubular function in Bobrowitz ID: Active tuberculosis undiagnosed until autopsy. Am J Med 1982; 72: non-oliguric acute renal failure. Am J Med 1982; 72: 642-649. 650-658. Glomerular and tubular function were evaluated in 30 non-oliguric patients with increasing az- Twenty-one patients in whom tuberculosis was the primary cause of death, but which was not otemia following open heart surgery. Fractional clearances (8) of test solutes relative to that diagnosed until necropsy, are reviewed. Df the 21 deaths, 11 were due to pulmonary tuberculosis of inulin were determined. In 16 patients, 0 dextran (radius 22 to 30 A) exceeded unity, a finding and 10 to miliary tuberculosis. Proper evaluation of the factors described in this study might attributed to inulin backleak through necrotic tubules. These patients were classified as having have led to the correct diagnosis in many of the patients. All but one patient in this series had acute renal failwe. In the remaining patients (N = 14), dkxVan was normal. These patients were fever. Failure to diminish the pyrexia which was believed to be due to specific lung infections, considered to have pm-renal failure. Clearance of inulin (Cl”) was lower in acute renal failure with presumably effective antibiotics, and the inability of the therapy to control other condiiions than in prerenal failure (12 f 2 versus 18 f 2 ml/min/ 1.73 m2; p <0.025). The apparent dif- though to cause the fever indicate the presence of tuberculosis. Tuberculosis, especially miliary ference in glomerular filtration rate when C&n is used as an index was abolished, however, when diseases, should be considered as a possible etiology of fever of unknown origin. If the diiis C,, in acute renal failure was corrected for tubule backleak of inulin. In acute renal failure, of tuberculosis is highly suggestive, even without bacteriologic confirmation, a therapeutic trial fractional clearance of p-aminohippurate (&,,) was 7.1 f 1.0. and fractional excretion of po- of antituberculosis drugs should be started. tassium (FEK) was 160 f 18 percent. These findings strongly suggest that secretory ability in both proximal and term!rial tubule segments, respectively, is preserved in acute renal failure. Anticoagulant therapy Heparin Warfarin Hear-l failure Cardiac disease Cardiotonlc agents Coumarlns Thrombosis Embollzatlon Deykin D: Current status of anticoagulant therapy. Am J Med 1982; 72: 659-664. Weber KT: New hope for the failing heart. Am J Med 1982; 72: 665-67 1. Anticoagulanttherapy has stood the test of time. Fulldose heparin and warfarin prevent recurring One sixth of this nation’s citizens have disease of the heart and blood vessels; an estimated pulmonary embolism and deep venous thrombosis. Their use is indicated in patients who have 3.5 to 4 million Americans have chronic cardiac failure. The individual and collective losses experienced venous thromboembolism unless contraindications are compelling. Lowdose associated with heart failure are enormous. Standard medical therapy with digitalis and diuretics heparin is successful in preventing the initial episode of venous thrombosis in most patients is frequently inadequate to control the morbidity associated with this oftentimes malignant at hii risk for the development of ttvombophlebitii. Warfarin reduces the incidence of systemic process. More effective medical therapy is therefore needed. The recent development of potent, embolization in patients with heart disease and atrial fibrillation and in patients with artificial orally active cardiotonic agents may make this objective a reality. At the present time, the new heart valves. Evidence is accumulating to suggest that warfarin may still retain an important cardiotonic agents are still in the experimental stages of investigation. Objective parameters role in the management of patients with myocardial infarction. However, bleeding remains an of ventricular function and the patients’ quality of life must be monitored if meaningful verdicts inevitable risk in patients receiving anticoagulant therapy. The risk, however, can be diminished are to be rendered. Information must be gathered that indicates whether prolonged therapy with when both the physician and patient understand the mechanism of action of the drugs and the these agents is detrimental to the myocardium. Despite this caveat, the availability of compounds factors that predispose to bleeding. having potent inotropic properties has generated much anticipation and excitement in clinical cardiology. Continued on page A62

Current status of anticoagulant therapy: Deykin D: Am J Med 1982; 72: 659–664

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Current status of anticoagulant therapy: Deykin D: Am J Med 1982; 72: 659–664

No

n-o

ligu

ric

acu

te r

enal

fai

lure

ln

ulin

bac

klea

k P

ulm

on

ary

tub

ercu

losi

s D

iag

no

sis

Lab

ora

tory

tes

ts

Tu

bu

le s

ecre

tio

n o

f P

AH

ln

ulin

cle

aran

ce

Tu

bu

le c

atio

n t

ran

spo

rt

Pat

ho

log

y R

oen

tgen

olo

gy

Mye

rs B

D,

Hilb

erm

an M

, S

pen

cer

RJ,

Jam

iso

n R

L:

Glo

mar

ula

r an

d t

ub

ula

r fu

nct

ion

in

B

ob

row

itz

ID:

Act

ive

tub

ercu

losi

s u

nd

iag

no

sed

un

til

auto

psy

. A

m

J M

ed

1982

; 72

: n

on

-olig

uri

c ac

ute

ren

al f

ailu

re.

Am

J M

ed 1

982;

72:

642

-649

. 65

0-65

8.

Glo

mer

ula

r an

d tu

bu

lar

fun

ctio

n w

ere

eval

uat

ed i

n 3

0 n

on

-olig

uri

c p

atie

nts

wit

h i

ncr

easi

ng

az-

T

wen

ty-o

ne

pat

ien

ts i

n w

ho

m t

ub

ercu

losi

s w

as t

he

pri

mar

y ca

use

of

dea

th,

bu

t wh

ich

was

no

t o

tem

ia f

ollo

win

g o

pen

hea

rt s

urg

ery.

Fra

ctio

nal

cle

aran

ces

(8)

of

test

so

lute

s re

lati

ve t

o t

hat

d

iag

no

sed

un

til n

ecro

psy

, ar

e re

view

ed.

Df

the

21 d

eath

s, 1

1 w

ere

du

e to

pu

lmo

nar

y tu

ber

culo

sis

of

inu

lin w

ere

det

erm

ined

. In

16

pat

ien

ts,

0 d

extr

an (rad

ius

22 t

o 3

0 A

) e

xce

ed

ed

un

ity,

a f

ind

ing

an

d 1

0 to

mili

ary

tub

ercu

losi

s.

Pro

per

eva

luat

ion

of

the

fact

ors

des

crib

ed i

n t

his

stu

dy

mig

ht

attr

ibu

ted

to i

nu

lin b

ackl

eak

thro

ug

h n

ecro

tic

tub

ule

s. T

hes

e p

atie

nts

wer

e cl

assi

fied

as

hav

ing

h

ave

led

to

th

e co

rrec

t d

iag

no

sis

in m

any

of

the

pat

ien

ts.

All

bu

t on

e p

atie

nt

in th

is s

erie

s h

ad

acu

te r

enal

fai

lwe.

In

the

rem

ain

ing

pat

ien

ts (

N =

14

), d

kxV

an w

as n

orm

al.

Th

ese

pat

ien

ts w

ere

feve

r. F

ailu

re t

o d

imin

ish

th

e p

yrex

ia w

hic

h w

as b

elie

ved

to

be

du

e to

sp

ecif

ic l

un

g in

fect

ion

s,

con

sid

ered

to

hav

e p

m-r

enal

fai

lure

. C

lear

ance

o

f in

ulin

(Cl”

) was

lo

wer

in

acu

te r

enal

fai

lure

w

ith

pre

sum

ably

eff

ecti

ve a

nti

bio

tics

, an

d th

e in

abili

ty o

f th

e th

erap

y to

co

ntr

ol o

ther

co

nd

iiio

ns

than

in

pre

ren

al f

ailu

re (

12 f

2

vers

us

18 f

2

ml/m

in/

1.73

m2;

p <

0.02

5).

Th

e ap

par

ent

dif

- th

ou

gh

to

cau

se t

he

feve

r in

dic

ate

the

pre

sen

ce o

f tu

ber

culo

sis.

Tu

ber

culo

sis,

esp

ecia

lly m

iliar

y fe

ren

ce i

n g

lom

eru

lar

filt

rati

on

rate

wh

en C

&n

is u

sed

as

an i

nd

ex w

as a

bo

lish

ed,

ho

wev

er,

wh

en

dis

ease

s, s

ho

uld

be

con

sid

ered

as

a p

oss

ible

eti

olo

gy

of

feve

r o

f u

nkn

ow

n o

rig

in. I

f th

e d

iiis

C,,

in a

cute

ren

al f

ailu

re w

as c

orr

ecte

d

for

tub

ule

bac

klea

k o

f in

ulin

. In

acu

te r

enal

fai

lure

, o

f tu

ber

culo

sis

is h

igh

ly s

ug

ges

tive

, eve

n w

ith

ou

t b

acte

rio

log

ic c

on

firm

atio

n, a

th

erap

euti

c tr

ial

frac

tio

nal

cle

aran

ce o

f p

-am

ino

hip

pu

rate

(&

,,)

was

7.1

f

1.0.

an

d f

ract

ion

al e

xcre

tio

n o

f p

o-

of

anti

tub

ercu

losi

s d

rug

s sh

ou

ld b

e st

arte

d.

tass

ium

(F

EK

) was

160

f

18 p

erce

nt.

Th

ese

fin

din

gs

stro

ng

ly s

ug

ges

t th

at s

ecre

tory

ab

ility

in

b

oth

pro

xim

al a

nd

term

!ria

l tu

bu

le s

egm

ents

, res

pec

tive

ly, i

s p

rese

rved

in a

cute

ren

al f

ailu

re.

An

tico

agu

lan

t th

erap

y H

epar

in

War

fari

n

Hea

r-l

failu

re

Car

dia

c d

isea

se

Car

dio

ton

lc

agen

ts

Co

um

arln

s T

hro

mb

osi

s E

mb

ollz

atlo

n

Dey

kin

D:

Cu

rren

t st

atu

s o

f an

tico

agu

lan

t th

erap

y. A

m J

Med

198

2; 7

2: 6

59-6

64.

Web

er

KT

: N

ew h

op

e fo

r th

e fa

ilin

g h

eart

. A

m J

Med

198

2; 7

2: 6

65-6

7 1.

An

tico

agu

lan

t th

erap

y h

as s

too

d th

e te

st o

f tim

e. F

ulld

ose

hep

arin

an

d w

arfa

rin

pre

ven

t re

curr

ing

O

ne

sixt

h o

f th

is n

atio

n’s

cit

izen

s h

ave

dis

ease

of

the

hea

rt a

nd

blo

od

ves

sels

; an

est

imat

ed

pu

lmo

nar

y em

bo

lism

an

d d

eep

ven

ou

s th

rom

bo

sis.

Th

eir

use

is

ind

icat

ed i

n p

atie

nts

wh

o h

ave

3.5

to 4

mill

ion

Am

eric

ans

hav

e ch

ron

ic c

ard

iac

failu

re.

Th

e in

div

idu

al a

nd

co

llect

ive

loss

es

exp

erie

nce

d

ven

ou

s th

rom

bo

emb

olis

m

un

less

co

ntr

ain

dic

atio

ns

are

com

pel

ling

. L

ow

do

se

asso

ciat

ed w

ith

hea

rt f

ailu

re a

re e

no

rmo

us.

Sta

nd

ard

med

ical

th

erap

y w

ith

dig

ital

is a

nd

diu

reti

cs

hep

arin

is

succ

essf

ul

in p

reve

nti

ng

th

e in

itia

l ep

iso

de

of

ven

ou

s th

rom

bo

sis

in m

ost

pat

ien

ts

is f

req

uen

tly

inad

equ

ate

to c

on

tro

l th

e m

orb

idit

y as

soci

ated

w

ith

th

is o

ften

tim

es

mal

ign

ant

at h

ii ri

sk f

or

the

dev

elo

pm

ent o

f tt

vom

bo

ph

leb

itii.

War

fari

n r

edu

ces

the

inci

den

ce o

f sy

stem

ic

pro

cess

. M

ore

eff

ecti

ve m

edic

al t

her

apy

is th

eref

ore

nee

ded

. Th

e re

cen

t d

evel

op

men

t o

f p

ote

nt,

em

bo

lizat

ion

in

pat

ien

ts w

ith

hea

rt d

isea

se a

nd

atr

ial

fib

rilla

tio

n a

nd

in

pat

ien

ts w

ith

art

ific

ial

ora

lly a

ctiv

e ca

rdio

ton

ic a

gen

ts m

ay m

ake

this

ob

ject

ive

a re

alit

y. A

t th

e p

rese

nt

tim

e, t

he

new

h

eart

val

ves.

Evi

den

ce i

s ac

cum

ula

tin

g t

o s

ug

ges

t th

at w

arfa

rin

may

sti

ll re

tain

an

im

po

rtan

t ca

rdio

ton

ic a

gen

ts a

re s

till

in th

e ex

per

imen

tal

stag

es o

f in

vest

igat

ion

. O

bje

ctiv

e p

aram

eter

s ro

le i

n th

e m

anag

emen

t o

f p

atie

nts

wit

h m

yoca

rdia

l in

farc

tio

n.

Ho

wev

er,

ble

edin

g r

emai

ns

an

of

ven

tric

ula

r fu

nct

ion

an

d t

he

pat

ien

ts’

qu

alit

y o

f lif

e m

ust

be

mo

nit

ore

d i

f mea

nin

gfu

l ve

rdic

ts

inev

itab

le ri

sk in

pat

ien

ts r

ecei

vin

g a

nti

coag

ula

nt

ther

apy.

Th

e ri

sk,

ho

wev

er,

can

be

dim

inis

hed

ar

e to

be

ren

der

ed.

Info

rmat

ion

mu

st b

e g

ath

ered

th

at in

dic

ates

wh

eth

er p

rolo

ng

ed th

erap

y w

ith

w

hen

bo

th th

e p

hys

icia

n a

nd

pat

ien

t u

nd

erst

and

the

mec

han

ism

of

acti

on

of

the

dru

gs

and

the

thes

e ag

ents

is d

etri

men

tal t

o t

he

myo

card

ium

. Des

pit

e th

is c

avea

t, t

he

avai

lab

ility

of

com

po

un

ds

fact

ors

th

at p

red

isp

ose

to

ble

edin

g.

hav

ing

po

ten

t in

otr

op

ic p

rop

erti

es h

as g

ener

ated

mu

ch a

nti

cip

atio

n a

nd

exc

item

ent

in c

linic

al

card

iolo

gy.

Con

tinue

d on

pag

e A

62